• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • Q&A
    • Videos
    • Comment
    • Analysis
    • People moves
    • In Profile
  •  
    Analysis
    • Videos
    • Q&A
    • Comment
    • In Profile
    • Podcast
    • Fundraising
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
UNQUOTE
  • Benelux

MedHold (Belgium) - Dec 2007

  • unquote
  • 01 December 2007
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Waterland Private Equity is to provide growth capital to the medical laboratory group MedHold, formed by the merger of AML-RIATOL and Medisch Labo D. Van Waes. Waterland will provide extra financing and support management where necessary in the continuous growth of the company.

Company

With a turnover of €37m, MedHold will be the second-largest Belgian private clinical laboratories group with a staff of 200. AML has been performing certain specialist analyses as a subcontractor for Labo Van Waes for the past 10 years. MedHold is planning substantial investments over the next few years. AML-Riatol is currently building a new laboratory in Hoboken, Antwerp, where the group will centre all its Antwerp activities from 2010. This will not have an impact on the activities of Labo van Waes, which will continue to operate as an independent laboratory from its base in Bruges.

People

Dirk Van Waes will continue to head Labo Van Waes’ activities and join the board of the merged group, which will be managed by Annie Vereecken and Geert Salembier from AML-RIATOL.

Sourced from: Benelux unquote" 55 (Jan 2008)

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Benelux
  • Expansion
  • Healthcare
  • Belgium

More on Benelux

Gimv acquires majority stake in Witec
Gimv acquires majority stake in Witec

Belgium-based Gimv set to support Netherlands-headquartered contract design manufacturer’s growth

  • Benelux
  • 26 April 2023
Bencis raises EUR 123m continuation fund for group of Fund IV assets
Bencis raises EUR 123m continuation fund for group of Fund IV assets

Secondary deal was led by Committed Advisors and will provide backing for future growth of four portfolio companies

  • Benelux
  • 30 March 2023
Holland exits Mauritskliniek in sale to PE-backed Corius
Holland exits Mauritskliniek in sale to PE-backed Corius

Sale of Dutch dermatology group comes nine months after regulator blocked sale to Triton's Bergman

  • Benelux
  • 16 September 2022
Unquote Private Equity Podcast: Growth equity's mounting momentum
Unquote Private Equity Podcast: Growth equity's mounting momentum

Bregal Milestoneт€™s Cyrus Shey and HPE Growthт€™s Manfred Krikke discuss investing, operational support and what's next for the industry

  • Benelux
  • 15 August 2022

Latest News

Partners Group to release IMs for Civica sale in mid-September
  • Exits
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions
  • Investments
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Czech Republic-headquartered family office is targeting DACH and CEE region deals

  • 01 September 2023
Redalpine expands leadership team amid CHF 1bn-plus fundraise
  • Venture
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • 31 August 2023
Change Ventures aims to hold final close for EUR 20m third fund by mid-2024
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds

  • 31 August 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013